88 related articles for article (PubMed ID: 29428316)
21. Differential diagnosis of prostate cancer and noncancerous tissue in the peripheral zone and central gland using the quantitative parameters of DCE-MRI: A meta-analysis.
Gao P; Shi C; Zhao L; Zhou Q; Luo L
Medicine (Baltimore); 2016 Dec; 95(52):e5715. PubMed ID: 28033274
[TBL] [Abstract][Full Text] [Related]
22. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
23. Intra- and inter-observer variability in dependence of T1-time correction for common dynamic contrast enhanced MRI parameters in prostate cancer patients.
Daniel M; Polanec SH; Wengert G; Clauser P; Pinker K; Helbich TH; Georg D; Baltzer PAT
Eur J Radiol; 2019 Jul; 116():27-33. PubMed ID: 31153570
[TBL] [Abstract][Full Text] [Related]
24. Improved repeatability of dynamic contrast-enhanced MRI using the complex MRI signal to derive arterial input functions: a test-retest study in prostate cancer patients.
Klawer EME; van Houdt PJ; Simonis FFJ; van den Berg CAT; Pos FJ; Heijmink SWTPJ; Isebaert S; Haustermans K; van der Heide UA
Magn Reson Med; 2019 May; 81(5):3358-3369. PubMed ID: 30656738
[TBL] [Abstract][Full Text] [Related]
25. The Impact of Arterial Input Function Determination Variations on Prostate Dynamic Contrast-Enhanced Magnetic Resonance Imaging Pharmacokinetic Modeling: A Multicenter Data Analysis Challenge.
Huang W; Chen Y; Fedorov A; Li X; Jajamovich GH; Malyarenko DI; Aryal MP; LaViolette PS; Oborski MJ; O'Sullivan F; Abramson RG; Jafari-Khouzani K; Afzal A; Tudorica A; Moloney B; Gupta SN; Besa C; Kalpathy-Cramer J; Mountz JM; Laymon CM; Muzi M; Schmainda K; Cao Y; Chenevert TL; Taouli B; Yankeelov TE; Fennessy F; Li X
Tomography; 2016 Mar; 2(1):56-66. PubMed ID: 27200418
[TBL] [Abstract][Full Text] [Related]
26. DCE-MRI protocol for constraining absolute pharmacokinetic modeling errors within specific accuracy limits.
Knight SP; Meaney JF; Fagan AJ
Med Phys; 2019 Aug; 46(8):3592-3602. PubMed ID: 31148187
[TBL] [Abstract][Full Text] [Related]
27. Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis.
Oto A; Yang C; Kayhan A; Tretiakova M; Antic T; Schmid-Tannwald C; Eggener S; Karczmar GS; Stadler WM
AJR Am J Roentgenol; 2011 Dec; 197(6):1382-90. PubMed ID: 22109293
[TBL] [Abstract][Full Text] [Related]
28. Quantitative diffusion-weighted imaging and dynamic contrast-enhanced characterization of the index lesion with multiparametric MRI in prostate cancer patients.
Yuan Q; Costa DN; Sénégas J; Xi Y; Wiethoff AJ; Rofsky NM; Roehrborn C; Lenkinski RE; Pedrosa I
J Magn Reson Imaging; 2017 Mar; 45(3):908-916. PubMed ID: 27442039
[TBL] [Abstract][Full Text] [Related]
29. Quantifying dynamic contrast-enhanced MRI of the knee in children with juvenile rheumatoid arthritis using an arterial input function (AIF) extracted from popliteal artery enhancement, and the effect of the choice of the AIF on the kinetic parameters.
Workie DW; Dardzinski BJ
Magn Reson Med; 2005 Sep; 54(3):560-8. PubMed ID: 16088875
[TBL] [Abstract][Full Text] [Related]
30. Automatic individual arterial input functions calculated from PCA outperform manual and population-averaged approaches for the pharmacokinetic modeling of DCE-MR images.
Sanz-Requena R; Prats-Montalbán JM; Martí-Bonmatí L; Alberich-Bayarri Á; García-Martí G; Pérez R; Ferrer A
J Magn Reson Imaging; 2015 Aug; 42(2):477-87. PubMed ID: 25410482
[TBL] [Abstract][Full Text] [Related]
31. Dynamic Contrast-Enhanced MR Perfusion in Differentiation of Benign and Malignant Brain Lesions.
Cetinkaya E; Aralasmak A; Atasoy B; Tokdemir S; Toprak H; Toprak A; Kurtcan S; Alkan A
Curr Med Imaging; 2022; 18(10):1099-1105. PubMed ID: 35331119
[TBL] [Abstract][Full Text] [Related]
32. Dual-input two-compartment pharmacokinetic model of dynamic contrast-enhanced magnetic resonance imaging in hepatocellular carcinoma.
Yang JF; Zhao ZH; Zhang Y; Zhao L; Yang LM; Zhang MM; Wang BY; Wang T; Lu BC
World J Gastroenterol; 2016 Apr; 22(13):3652-62. PubMed ID: 27053857
[TBL] [Abstract][Full Text] [Related]
33. Assessment of liver fibrosis using pharmacokinetic parameters of dynamic contrast-enhanced magnetic resonance imaging.
Li Z; Sun J; Chen L; Huang N; Hu P; Hu X; Han G; Zhou Y; Bai W; Niu T; Yang X
J Magn Reson Imaging; 2016 Jul; 44(1):98-104. PubMed ID: 26707910
[TBL] [Abstract][Full Text] [Related]
34. Characteristics of quantitative perfusion parameters on dynamic contrast-enhanced MRI in mammographically occult breast cancer.
Ryu JK; Rhee SJ; Song JY; Cho SH; Jahng GH
J Appl Clin Med Phys; 2016 Sep; 17(5):377-390. PubMed ID: 27685105
[TBL] [Abstract][Full Text] [Related]
35. A simulation study comparing nine mathematical models of arterial input function for dynamic contrast enhanced MRI to the Parker model.
He D; Xu L; Qian W; Clarke J; Fan X
Australas Phys Eng Sci Med; 2018 Jun; 41(2):507-518. PubMed ID: 29569210
[TBL] [Abstract][Full Text] [Related]
36. Low-risk prostate cancer: the accuracy of multiparametric MR imaging for detection.
Kim JY; Kim SH; Kim YH; Lee HJ; Kim MJ; Choi MS
Radiology; 2014 May; 271(2):435-44. PubMed ID: 24484061
[TBL] [Abstract][Full Text] [Related]
37. Investigation and optimization of parameter accuracy in dynamic contrast-enhanced MRI.
Cheng HL
J Magn Reson Imaging; 2008 Sep; 28(3):736-43. PubMed ID: 18777534
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of normal prostate tissue, chronic prostatitis, and prostate cancer by quantitative perfusion analysis using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence.
Franiel T; Lüdemann L; Rudolph B; Rehbein H; Staack A; Taupitz M; Prochnow D; Beyersdorff D
Invest Radiol; 2008 Jul; 43(7):481-7. PubMed ID: 18580330
[TBL] [Abstract][Full Text] [Related]
39. Differentiation of High-Grade from Low-Grade Astrocytoma: Improvement in Diagnostic Accuracy and Reliability of Pharmacokinetic Parameters from DCE MR Imaging by Using Arterial Input Functions Obtained from DSC MR Imaging.
You SH; Choi SH; Kim TM; Park CK; Park SH; Won JK; Kim IH; Lee ST; Choi HJ; Yoo RE; Kang KM; Yun TJ; Kim JH; Sohn CH
Radiology; 2018 Mar; 286(3):981-991. PubMed ID: 29244617
[TBL] [Abstract][Full Text] [Related]
40. Comparison of intravoxel incoherent motion diffusion-weighted MR imaging with dynamic contrast-enhanced MRI for differentiating lung cancer from benign solitary pulmonary lesions.
Yuan M; Zhang YD; Zhu C; Yu TF; Shi HB; Shi ZF; Li H; Wu JF
J Magn Reson Imaging; 2016 Mar; 43(3):669-79. PubMed ID: 26340144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
